Overview
Glen Kennedy practices in Herston, Australia. Mr. Kennedy is highly rated in 3 conditions, according to our data. His top areas of expertise are Graft Versus Host Disease (GvHD), COVID-19, Febrile Neutropenia, Bone Marrow Transplant, and Mastoidectomy.
His clinical research consists of co-authoring 114 peer reviewed articles and participating in 1 clinical trial. MediFind looks at clinical research from the past 15 years.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
1 Clinical Trials
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Distinguished
- Bone Marrow TransplantMr. Kennedy isDistinguished. Learn about Bone Marrow Transplant.
- Advanced
- COVID-19Mr. Kennedy isAdvanced. Learn about COVID-19.
- Graft Versus Host Disease (GvHD)Mr. Kennedy isAdvanced. Learn about Graft Versus Host Disease (GvHD).
- Experienced
- Acute Lymphoblastic Leukemia (ALL)Mr. Kennedy isExperienced. Learn about Acute Lymphoblastic Leukemia (ALL).
- Acute Myeloid Leukemia (AML)Mr. Kennedy isExperienced. Learn about Acute Myeloid Leukemia (AML).
- Alopecia AreataMr. Kennedy isExperienced. Learn about Alopecia Areata.
- Anaplastic Large Cell LymphomaMr. Kennedy isExperienced. Learn about Anaplastic Large Cell Lymphoma.
- Autosomal Recessive HypotrichosisMr. Kennedy isExperienced. Learn about Autosomal Recessive Hypotrichosis.
- Chediak-Higashi SyndromeMr. Kennedy isExperienced. Learn about Chediak-Higashi Syndrome.